Investors can reap benefits
Two fund managers and one analyst added to team
Former country head UK at Eaton Vance Investment Managers
Candriam chief executive Naïm Abou-Jaoudé will serve a two-year term as EFAMA president
Investor Statement on Facial Recognition launched
Main focus on pharma and biotech
Market to reach $9.6bn by 2022